Avid Bioservices Inc (CDMO)

[cjgaddy]

ROTH/Pantginis 10-30-14 Update on MSTO’14 Frontline/NSCLC IST/UNC data release…
Roth Capital /Joe Pantginis - init. 7-15-10 Buy/PT=$10, CURR: Buy/$5 http://www.roth.com
. . .Universe (click link bottom right): http://roth.bluematrix.com/docs/pdf/BLUE.pdf

MSTO’14/Chicago, J.Grilley-Olson’s Poster on Bavi+CP IST(UNC/U-Pitt) vs. Frontline Stage4 NSCLC), n=23, single-arm.
• Bavi+CP => MOS=12.2mos(HistCtl=~9.8mos), PFS=4.8mos, ORR=35%












.
.
= = = = = = = = = = = = = = = = = = = = =
K. 3rd IST Trial (Bavi+PemCarbo vs. Frontline NSCLC (Stage4), open-label Ph.1B, n=25)
Protocol: http://clinicaltrials.gov/ct2/show/NCT01323062
…10-30-14: Interim data n=23, MSTO’14: MOS=12.2mos, PFS=4.8mos, ORR=35% http://tinyurl.com/mll62c6
...9-9-14: Stage IV NSCLC IST Enrollment complete. http://tinyurl.com/ktrfswj
...4-2012: Clinicaltrials.gov shows 2nd site added: Univ. of Pittsburg
...4-2-12 AACR'12: "5pts. to-date, 3 have PR's" http://tinyurl.com/7yrwqm7 (see #1744)
...3-8-11: IST (NSCLC) initiated at UNC (PI= J.Grilley-Olson), ~25 patients - http://tinyurl.com/6b926ku